Sensei Biotherapeutics, Inc

Sensei Biotherapeutics, Inc Overview

Company Headquarters: Massachusetts, US

Founded: 1999

Workforce: ~56

Company Working: Sensei Biotherapeutics is the fastest-growing biopharmaceutical company, which is engaged in the discovery, and development of next-generation immunotherapies with an initial focus on treatments for cancer. The company is majorly involved in the development of novel product candidates that integrate next-generation technologies. The company developed a strong set of R&D capabilities and infrastructure to provide support for the discovery and advancement of antibody product candidates. The company has a strong distribution network in North America, Europe, Asia-Pacific, and the Rest of the World.

Strategy

Sensei Biotherapeutics is focused on the development of antibodies for the treatment of tumors. The company utilizes a combination of committed commercial resources, regional commercial resources, and distributorships to market, sell, and distribute its products across the globe. It also focuses on winning in established markets, accelerating development in emerging markets, innovating for value, simplifying, and improving the operating model, and supplementing organic growth.

Company Snapshot

56

Employees

1999

Founded

Massachusetts, US

Headquarters

SWOT Analysis

Strengths

Strong R&D facilities
Trusted brand name
Robust sales and marketing capabilities

Weaknesses

Limited penetration in developing markets

Opportunities

Collaboration with regional players to expand geographic boundaries
Statergic alliance for business expansion

Threats

Stringent government regulations
Changing customer preference
Intense competition

Key Developments

Date	Approach	Development
May 2020	Acquisition	Sensei Biotherapeutics announced the acquisition of Alvaxa Biosciences (US) a camelid antibody therapeutics company. As per the agreement Sensei acquired camelid nanobody libraries which is expertise in nanobody discovery. Through this acquisition, the company boosts its business growth in the nanobody market.

Product Offering

Sensei Biotherapeutics, Inc
- Nanobody

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.